What it is (overview)

A mediastinal biopsy with imaging guidance is a diagnostic procedure that removes a small tissue sample from the mediastinum—the central area of the thoracic cavity between the lungs that contains lymph nodes, major blood vessels, the trachea (windpipe), and other important structures. Because the mediastinum is close to vital organs, doctors often use imaging guidance—most commonly a CT scan (computed tomography) or sometimes ultrasound—to accurately target the abnormal area while minimizing risk.

The tissue obtained is examined by a pathologist under a microscope and may also be tested with specialized lab techniques (for example, stains, cultures, or molecular tests). The biopsy does not “measure” a number like a blood test; instead, it helps answer questions such as:

• Is the mass or enlarged lymph node cancerous?
• If it is cancer, what type is it? (For example, lung cancer spread to mediastinal lymph nodes vs. lymphoma.)
• Is it an infection or inflammation? (For example, tuberculosis or sarcoidosis.)

What results mean in plain language: A “benign” result suggests no cancer was seen in the sampled tissue, though your doctor will interpret this alongside imaging and symptoms (sometimes a repeat biopsy is needed if suspicion remains). A “malignant” result means cancer cells were found, and the report usually specifies the cancer type and features that guide treatment. Results indicating infection or inflammatory disease can help direct antibiotics, anti-inflammatory therapy, or further testing.

When & why it's usually done

This test is usually ordered when imaging (such as a chest CT scan, PET/CT, or chest X-ray) shows an abnormality in the mediastinum—like a mass or enlarged lymph nodes—and a definite diagnosis is needed. Doctors choose imaging-guided biopsy to improve accuracy, especially when the target is small, deep, or close to critical structures.

Common reasons your clinician may recommend a mediastinal biopsy with medical imaging guidance include:

• Suspicion of lung cancer or another cancer, especially to determine whether mediastinal lymph nodes are involved (important for staging and treatment planning).
• Evaluation of a mediastinal mass found on imaging (for example, thymic tumors, lymphoma, or germ cell tumors).
• Unexplained enlarged mediastinal lymph nodes (mediastinal lymphadenopathy) that could be due to cancer, infection, or inflammatory disease.
• Persistent symptoms that may be related to mediastinal disease, such as chronic cough, chest discomfort/pressure, shortness of breath, hoarseness, or unexplained weight loss, night sweats, or fever.
• Concern for infection (such as tuberculosis or fungal infection), especially in people with risk factors like immune suppression or relevant exposures/travel history.
• Clarifying inconclusive prior tests, such as when sputum tests, bloodwork, or less invasive biopsies did not provide a diagnosis.

Imaging guidance (CT scan or ultrasound) helps the clinician choose the safest path to the target area and confirms the needle is in the right place, improving the chance of getting a high-quality tissue sample while reducing complications.

Common diseases related to it

• Lung cancer (including non-small cell and small cell lung cancer) with possible mediastinal lymph node involvement
• Lymphoma (Hodgkin and non-Hodgkin lymphoma)
• Metastatic cancer to mediastinal lymph nodes (spread from other cancers)
• Sarcoidosis
• Tuberculosis (TB)
• Fungal infections (such as histoplasmosis, depending on region/exposures)
• Thymoma and other thymic tumors
• Germ cell tumors of the mediastinum
• Benign reactive lymph node enlargement (non-cancerous inflammation)

Health goals where it may help

• Confirming or ruling out cancer to enable timely treatment decisions
• Accurate cancer staging (especially for lung cancer) to guide surgery, radiation, targeted therapy, or immunotherapy
• Identifying infection sources to select the most effective antimicrobial treatment
• Distinguishing inflammatory conditions (such as sarcoidosis) from malignancy to avoid unnecessary treatments
• Reducing diagnostic uncertainty after abnormal chest imaging of the mediastinum or thoracic cavity
• Planning next steps when a mediastinal mass or enlarged lymph nodes are found on CT scan or other medical imaging